[Current Status and Perspective of Chemoradiotherapy for Uterine Cervical Cancer].
Fifteen years has passed since the NCI announced the clinical importance of concurrent chemoradiotherapy (CCRT) in radiotherapy for patients with locoregionally advanced uterine cervical cancer. Numerous clinical trials have been performed to further improve the outcomes of CCRT. In addition to investigations of chemotherapeutic regimens and schedules, adaptation of novel radiotherapy methods such as image-guided brachytherapy (IGBT) and intensity-modulated radiotherapy (IMRT) is encouraged in CCRT for cervical cancer.
Dept. of Radiology, Graduate School of Medical Science, University of the Ryukyus.
Takafumi
T
Toita
Takuro
T
Ariga
Goro
G
Kasuya
Seiji
S
Hashimoto
Hitoshi
H
Maemoto
Joichi
J
Heianna
Yasumasa
Y
Kakinohana
Sadayuki
S
Murayama
D059248:Chemoradiotherapy / Q000009:adverse effects; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D058990:Molecular Targeted Therapy; D011879:Radiotherapy Dosage; D050397:Radiotherapy, Intensity-Modulated; D002583:Uterine Cervical Neoplasms / Q000473:pathology / Q000628:therapy*